Q1 2024 EPS Estimates for goeasy Ltd. (TSE:GSY) Raised by Cormark

goeasy Ltd. (TSE:GSY) – Cormark boosted their Q1 2024 earnings estimates for shares of goeasy in a research note issued to investors on Thursday, April 18th. Cormark analyst J. Fenwick now forecasts that the company will post earnings of $3.82 per share for the quarter, up from their prior forecast of $3.71. Cormark currently has a “Buy” rating and a $200.00 target price on the stock. The consensus estimate for goeasy’s current full-year earnings is $16.58 per share. Cormark also issued estimates for goeasy’s Q3 2024 earnings at $4.41 EPS, Q4 2024 earnings at $4.67 EPS, Q1 2025 earnings at $4.82 EPS, Q2 2025 earnings at $4.85 EPS, Q3 2025 earnings at $5.39 EPS, Q4 2025 earnings at $5.68 EPS and FY2025 earnings at $20.73 EPS.

Several other equities research analysts have also recently issued reports on the stock. National Bankshares boosted their price objective on shares of goeasy from C$190.00 to C$195.00 and gave the company an “outperform” rating in a research report on Wednesday, February 14th. Desjardins upped their price target on shares of goeasy from C$165.00 to C$185.00 and gave the stock a “buy” rating in a research report on Friday, February 9th. Scotiabank upped their price target on shares of goeasy from C$145.00 to C$170.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 31st. Raymond James upped their price target on shares of goeasy from C$166.00 to C$200.00 and gave the stock an “outperform” rating in a research report on Thursday, February 15th. Finally, Royal Bank of Canada upped their price target on shares of goeasy from C$193.00 to C$195.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 14th. One research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, goeasy presently has an average rating of “Moderate Buy” and an average target price of C$189.11.

goeasy Price Performance

goeasy stock opened at C$173.43 on Monday. The stock has a market cap of C$2.88 billion, a price-to-earnings ratio of 11.98, a price-to-earnings-growth ratio of 0.84 and a beta of 2.03. The company has a debt-to-equity ratio of 278.25, a current ratio of 15.62 and a quick ratio of 28.46. goeasy has a 1 year low of C$87.00 and a 1 year high of C$180.10. The firm has a 50-day moving average of C$165.45 and a two-hundred day moving average of C$148.63.

goeasy (TSE:GSY) last released its quarterly earnings data on Tuesday, February 13th. The company reported C$4.01 earnings per share (EPS) for the quarter, beating the consensus estimate of C$3.92 by C$0.09. The company had revenue of C$338.11 million during the quarter, compared to analysts’ expectations of C$340.35 million. goeasy had a net margin of 33.21% and a return on equity of 25.77%.

Insider Transactions at goeasy

In other news, Director David Ingram sold 30,000 shares of the firm’s stock in a transaction dated Wednesday, February 21st. The shares were sold at an average price of C$157.58, for a total value of C$4,727,400.00. Insiders own 22.53% of the company’s stock.

goeasy Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were paid a $1.17 dividend. This is an increase from goeasy’s previous quarterly dividend of $0.96. This represents a $4.68 annualized dividend and a dividend yield of 2.70%. The ex-dividend date was Wednesday, March 27th. goeasy’s dividend payout ratio (DPR) is currently 32.32%.

About goeasy

goeasy Ltd. provides non-prime leasing and lending services under the easyhome, easyfinancial, and LendCare brands to consumers in Canada. The company operates through two segments, Easyfinancial and Easyhome. It offers unsecured and secured installment loans; home equity secured instalment loans and automotive vehicle financing; and loans to finance the purchase of retail goods, powersports and recreational vehicles, home improvement projects, and healthcare related products and services.